On the recordJuly 27, 2022
The FDA needs to provide regulatory pathways for products containing CBD. The FDA needs to act now.
Said by
Ryan F. Quarles
Source
congress.govRyan F. Quarles: “The FDA needs to provide regulatory pathways for products containing CBD. The FDA needs to act now.”
Editor's note · Context
Quarles emphasizes the urgency for FDA guidance on CBD products to stimulate investment.
Share
More from Ryan F. Quarles
Nov 13, 2018
It is not our intention. Indeed, it is the opposite of our intention, to affect the total loss-absorbing capacity of the largest firms.
Jul 27, 2022
We feel strongly that hemp is a commodity crop. It is legal to produce and that we should not be criminalizing or intending to criminalize producers for producing a legal crop.
Apr 16, 2018
I do think that certainly, the way that we have implemented the Volcker Rule... it has been excessively burdensome.
Apr 18, 2018
That is probably the highest priority item that we have, discussing ways to ensure that our systems are resilient.